A beneficial role of cardiac P2X 4 receptors in heart failure: Rescue of the calsequestrin overexpression model of cardiomyopathy

Alexander Yang, Dimitry Sonin, Larry Jones, William H. Barry, Bruce T. Liang

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

The P2X 4 purinergic receptor (P2X 4R) is a ligand-gated ion channel. Its activation by extracellular ATP results in Ca 2+ influx. Transgenic cardiac overexpression of the human P2X 4 receptor showed an in vitro phenotype of enhanced basal contractility. The objective here was to determine the in vivo cardiac physiological role of this receptor. Specifically, we tested the hypothesis that this receptor plays an important role in modulating heart failure progression. Transgenic cardiac overexpression of canine calsequestrin (CSQ) showed hypertrophy, heart failure, and premature death. Crossing the P2X 4R mouse with the CSQ mouse more than doubled the lifespan (182 ± 91 days for the binary CSQ/P2X 4R mouse, n = 35) of the CSQ mouse (71.3 ± 25.4 days, n = 50, P < 0.0001). The prolonged survival in the binary CSQ/P2X 4R mouse was associated with an improved left ventricular weight-to-body weight ratio and a restored β-adrenergic responsiveness. The beneficial phenotype of the binary mouse was not associated with any downregulation of the CSQ level but-correlated with improved left ventricular developed pressure and ±dP/dt. The enhanced cardiac performance was manifested in young binary animals and persisted in older animals. The increased contractility likely underlies the survival benefit from P2X 4 receptor overexpression. An increased expression or activation of this receptor may represent a new approach in the therapy of heart failure.

Original languageEnglish
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume287
Issue number3 56-3
DOIs
StatePublished - Sep 2004

Fingerprint

Calsequestrin
Purinergic P2X Receptors
Cardiomyopathies
Heart Failure
Ligand-Gated Ion Channels
Phenotype
Premature Mortality
Survival
Ventricular Pressure
Adrenergic Agents
Hypertrophy
Canidae
Down-Regulation
Adenosine Triphosphate
Body Weight
Weights and Measures

Keywords

  • Adenine nucleotide
  • Cardiac failure
  • Contraction
  • Isoproterenol
  • Purines

ASJC Scopus subject areas

  • Physiology

Cite this

A beneficial role of cardiac P2X 4 receptors in heart failure : Rescue of the calsequestrin overexpression model of cardiomyopathy. / Yang, Alexander; Sonin, Dimitry; Jones, Larry; Barry, William H.; Liang, Bruce T.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 287, No. 3 56-3, 09.2004.

Research output: Contribution to journalArticle

@article{8891ffeb05d445829a19730dd7a02212,
title = "A beneficial role of cardiac P2X 4 receptors in heart failure: Rescue of the calsequestrin overexpression model of cardiomyopathy",
abstract = "The P2X 4 purinergic receptor (P2X 4R) is a ligand-gated ion channel. Its activation by extracellular ATP results in Ca 2+ influx. Transgenic cardiac overexpression of the human P2X 4 receptor showed an in vitro phenotype of enhanced basal contractility. The objective here was to determine the in vivo cardiac physiological role of this receptor. Specifically, we tested the hypothesis that this receptor plays an important role in modulating heart failure progression. Transgenic cardiac overexpression of canine calsequestrin (CSQ) showed hypertrophy, heart failure, and premature death. Crossing the P2X 4R mouse with the CSQ mouse more than doubled the lifespan (182 ± 91 days for the binary CSQ/P2X 4R mouse, n = 35) of the CSQ mouse (71.3 ± 25.4 days, n = 50, P < 0.0001). The prolonged survival in the binary CSQ/P2X 4R mouse was associated with an improved left ventricular weight-to-body weight ratio and a restored β-adrenergic responsiveness. The beneficial phenotype of the binary mouse was not associated with any downregulation of the CSQ level but-correlated with improved left ventricular developed pressure and ±dP/dt. The enhanced cardiac performance was manifested in young binary animals and persisted in older animals. The increased contractility likely underlies the survival benefit from P2X 4 receptor overexpression. An increased expression or activation of this receptor may represent a new approach in the therapy of heart failure.",
keywords = "Adenine nucleotide, Cardiac failure, Contraction, Isoproterenol, Purines",
author = "Alexander Yang and Dimitry Sonin and Larry Jones and Barry, {William H.} and Liang, {Bruce T.}",
year = "2004",
month = "9",
doi = "10.1152/ajpheart.00079.2004",
language = "English",
volume = "287",
journal = "American Journal of Physiology",
issn = "0193-1857",
publisher = "American Physiological Society",
number = "3 56-3",

}

TY - JOUR

T1 - A beneficial role of cardiac P2X 4 receptors in heart failure

T2 - Rescue of the calsequestrin overexpression model of cardiomyopathy

AU - Yang, Alexander

AU - Sonin, Dimitry

AU - Jones, Larry

AU - Barry, William H.

AU - Liang, Bruce T.

PY - 2004/9

Y1 - 2004/9

N2 - The P2X 4 purinergic receptor (P2X 4R) is a ligand-gated ion channel. Its activation by extracellular ATP results in Ca 2+ influx. Transgenic cardiac overexpression of the human P2X 4 receptor showed an in vitro phenotype of enhanced basal contractility. The objective here was to determine the in vivo cardiac physiological role of this receptor. Specifically, we tested the hypothesis that this receptor plays an important role in modulating heart failure progression. Transgenic cardiac overexpression of canine calsequestrin (CSQ) showed hypertrophy, heart failure, and premature death. Crossing the P2X 4R mouse with the CSQ mouse more than doubled the lifespan (182 ± 91 days for the binary CSQ/P2X 4R mouse, n = 35) of the CSQ mouse (71.3 ± 25.4 days, n = 50, P < 0.0001). The prolonged survival in the binary CSQ/P2X 4R mouse was associated with an improved left ventricular weight-to-body weight ratio and a restored β-adrenergic responsiveness. The beneficial phenotype of the binary mouse was not associated with any downregulation of the CSQ level but-correlated with improved left ventricular developed pressure and ±dP/dt. The enhanced cardiac performance was manifested in young binary animals and persisted in older animals. The increased contractility likely underlies the survival benefit from P2X 4 receptor overexpression. An increased expression or activation of this receptor may represent a new approach in the therapy of heart failure.

AB - The P2X 4 purinergic receptor (P2X 4R) is a ligand-gated ion channel. Its activation by extracellular ATP results in Ca 2+ influx. Transgenic cardiac overexpression of the human P2X 4 receptor showed an in vitro phenotype of enhanced basal contractility. The objective here was to determine the in vivo cardiac physiological role of this receptor. Specifically, we tested the hypothesis that this receptor plays an important role in modulating heart failure progression. Transgenic cardiac overexpression of canine calsequestrin (CSQ) showed hypertrophy, heart failure, and premature death. Crossing the P2X 4R mouse with the CSQ mouse more than doubled the lifespan (182 ± 91 days for the binary CSQ/P2X 4R mouse, n = 35) of the CSQ mouse (71.3 ± 25.4 days, n = 50, P < 0.0001). The prolonged survival in the binary CSQ/P2X 4R mouse was associated with an improved left ventricular weight-to-body weight ratio and a restored β-adrenergic responsiveness. The beneficial phenotype of the binary mouse was not associated with any downregulation of the CSQ level but-correlated with improved left ventricular developed pressure and ±dP/dt. The enhanced cardiac performance was manifested in young binary animals and persisted in older animals. The increased contractility likely underlies the survival benefit from P2X 4 receptor overexpression. An increased expression or activation of this receptor may represent a new approach in the therapy of heart failure.

KW - Adenine nucleotide

KW - Cardiac failure

KW - Contraction

KW - Isoproterenol

KW - Purines

UR - http://www.scopus.com/inward/record.url?scp=4143150614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4143150614&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.00079.2004

DO - 10.1152/ajpheart.00079.2004

M3 - Article

C2 - 15130891

AN - SCOPUS:4143150614

VL - 287

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0193-1857

IS - 3 56-3

ER -